Non-essential drugs for medical insurance refer to drugs that are within the scope of medical insurance reimbursement, but not in the national essential drugs list. Compared with basic drugs, these drugs may be more suitable for treating certain diseases, but their prices are relatively higher, and some of them can even reach thousands of prices. Therefore, more consideration should be given to the use of non-basic drugs in medical insurance, and the principles of medical norms and economic rationality should be followed.

The reimbursement of medical insurance non-basic drugs must meet the following conditions: First, the treatment object must be identified as a patient who needs the drug treatment; Second, it needs to be reviewed by experts, and it is considered that the drug has therapeutic necessity and effect; Third, patients have tried to use other basic drugs and have not achieved satisfactory results. At the same time, the purchase and use of medical insurance non-base drugs should follow specific processes and procedures to ensure proper and reasonable use.

With the continuous progress of medical technology and drug research and development, the demand for the introduction and use of new drugs is gradually increasing. However, the medical insurance fund is limited, and the price of non-basic medical insurance drugs is high, so the affordability of patients and social economy should still be considered in the subsequent management and reimbursement. Therefore, it is necessary to establish a reasonable and effective management mechanism for the use of non-basic drugs in medical insurance, strengthen cooperation with many parties, and ensure the sustainability of medical insurance funds.